Your browser doesn't support javascript.
loading
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial).
Olofsson Bagge, Roger; Nelson, Axel; Shafazand, Amir; All-Eriksson, Charlotta; Cahlin, Christian; Elander, Nils; Helgadottir, Hildur; Kiilgaard, Jens Folke; Kinhult, Sara; Ljuslinder, Ingrid; Mattsson, Jan; Rizell, Magnus; Sternby Eilard, Malin; Ullenhag, Gustav J; Nilsson, Jonas A; Ny, Lars; Lindnér, Per.
Afiliación
  • Olofsson Bagge R; Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Nelson A; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Shafazand A; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • All-Eriksson C; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Cahlin C; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Elander N; Department of Radiology, Alingsås Hospital, Alingsås, Sweden.
  • Helgadottir H; Department of Ophthalmology, Mölndal Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Kiilgaard JF; Transplant Institute, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Kinhult S; Department of Oncology and Department of Clinical and Biomedical Sciences, Linköping University, Linköping, Sweden.
  • Ljuslinder I; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Mattsson J; Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital Copenhagen, Copenhagen, Denmark.
  • Rizell M; Department of Oncology, Skåne University Hospital, Lund, Sweden.
  • Sternby Eilard M; Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden.
  • Ullenhag GJ; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Nilsson JA; Transplant Institute, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Ny L; Transplant Institute, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Lindnér P; Department of Immunology, Genetics and Pathology (IGP), Science for Life Laboratories, Uppsala University, Uppsala, Sweden.
J Clin Oncol ; 41(16): 3042-3050, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36940407
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hepáticas / Melfalán Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Hepáticas / Melfalán Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos